Vancouver, British Columbia, and Rehovot, Israel–(Newsfile Corp. – March 11, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or “the Company”) invites its shareholders and the...
New name to reflect the Biotech power of combining plant cell growth with elicitation of specific molecules to produce unique compounds of high human utility value...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – February 10, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE:8MV) (“BioHarvest” or “the Company”) a fast-growing Biotech firm...
Vancouver, British Columbia, and Rehovot, Israel–(Newsfile Corp. – February 3, 2022) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or “the Company”) is pleased to announce that...
2022 Revenue will include sales of VINIA® and Cannabis, both with high gross margins Major investments in the BioFarming platform and Intellectual property New patent application...
The Company is now producing Cannabis in industrial scale bioreactors and has entered the final stage of its Cannabis commercialization program Vancouver, British Columbia, and Rehovot,...
17% quarter-over-quarter growth with record VINIA® global sales orders in Q4 of USD 825k 485% year-over-year growth with total sales orders of USD 2.4M in 2021...
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – December 30, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (“BioHarvest” or the “Company”) is pleased to...
Cannabis produced has a Trichomes density of up to 200 times greater than in a plant-grown product while solving major industry challenges of consistency, safety, and...
The new factory is ready to start production to meet the increased demand for VINIA® On track for the conversion of the existing 2 tons/year facility...